Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Egerton

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Schizophrenia (Heidelberg, Germany)|March 3, 2022
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophreniaFanni Krajner, Laila Hadaya, Grant McQueen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 2022
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaborationAlice Egerton, Kira Griffiths, Cecila Casetta, et al.
Biological Psychiatry|February 9, 2025
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for PsychosisSamuel R Knight, Leyla Abbasova, Yashar Zeighami, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort studyEmma Butler, Toby Pillinger, Kirsten Brown, et al.
BMJ Open|November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort studyEdward Millgate, Kira Griffiths, Alice Egerton, et al.
Schizophrenia Bulletin|January 7, 2017
Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for PsychosisAlice Egerton, Oliver D Howes, Sylvain Houle, et al.
Schizophrenia Bulletin|March 14, 2023
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical TrialSubash Raj Susai, Melanie Föcking, David Mongan, et al.
The International Journal of Neuropsychopharmacology|December 12, 2025
Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosisAmanda Kiemes, Nicholas R Livingston, Paulina B Lukow, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Longitudinal brain structural changes during clozapine treatment: associations with neuroreceptor architecture and clinical responseBridget King, Dara M Cannon, Nicolas A Crossley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 24, 2024
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosisNicholas R Livingston, Amanda Kiemes, Gabriel A Devenyi, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Schizophrenia (Heidelberg, Germany)|March 3, 2022
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophreniaFanni Krajner, Laila Hadaya, Grant McQueen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 2022
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaborationAlice Egerton, Kira Griffiths, Cecila Casetta, et al.
Biological Psychiatry|February 9, 2025
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for PsychosisSamuel R Knight, Leyla Abbasova, Yashar Zeighami, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort studyEmma Butler, Toby Pillinger, Kirsten Brown, et al.
BMJ Open|November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort studyEdward Millgate, Kira Griffiths, Alice Egerton, et al.
Schizophrenia Bulletin|January 7, 2017
Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for PsychosisAlice Egerton, Oliver D Howes, Sylvain Houle, et al.
Schizophrenia Bulletin|March 14, 2023
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical TrialSubash Raj Susai, Melanie Föcking, David Mongan, et al.
The International Journal of Neuropsychopharmacology|December 12, 2025
Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosisAmanda Kiemes, Nicholas R Livingston, Paulina B Lukow, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Longitudinal brain structural changes during clozapine treatment: associations with neuroreceptor architecture and clinical responseBridget King, Dara M Cannon, Nicolas A Crossley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 24, 2024
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosisNicholas R Livingston, Amanda Kiemes, Gabriel A Devenyi, et al.
Pageof 10